Stem cell, drug discovery, and analytical services
All services
Clinical Stem Cell Services
Preclinical & Drug Discovery CRO
Human Tissue Samples
Cells and products for stem cell research and 3D cell culture
Featured products
All products
Our product catalog covers the territories of REPROCELL USA (Americas), REPROCELL Europe (EMEA), and Bioserve India.
Stem Cell Reagents
Cells
Stem Cell Products
3D Cell Culture
Labware
Learning resources and technical support online
All learning resources
The REPROCELL Blog
More on the blog
Integrating AI with Ex Vivo Data: How Machine Learning Is Enhancing Predictive Accuracy in Human Tissue Studies
12 February 2026
The Critical Role of Central Laboratory Services in Regulatory Compliance and Data Integrity
27 January 2026
Latest Webinars
More webinars
Webinar: Innovative Cell Technologies to Bioengineer Human Tissues In Vitro for Use in R&D and Modelling Human Disease
Webinar: Raising the Standard: High-Quality and Reproducible Growth Factors for Advanced Cell Systems
Dr. Luana FerrarQkine
Upcoming Webinars
REPROCELL is all about improving human health through biomedical innovation and discovery
REPROCELL Brands
Upcoming Conferences
More upcoming events
Phacilitate Advanced Therapies Week
9-12 February 2026
ELRIG Cell and Gene Therapy
9-10 March 2026
Advanced Therapies UK
17-18 March 2026
AACR Annual Meeting
17-22 April 2026
Corporate News
More corporate news
REPROCELL Launches StemEdit: Clinical Gene Editing Services and New iPSC Lines Using AI-Designed Editing System
28 January 2026
REPROCELL Announces the Commercial Launch of its StemEdit Hypoimmune hiPSC Lines Generated with Advanced Gene Editing Innovations
7 November 2025
Information for investors
Make an inquiry
Connect with our expert scientists and sales teams worldwide. We will figure out who's best to reply to you.
Contact us other ways
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP)
Investor Relations